The Karnataka government has banned 15 drugs and cosmetic products deemed "Not of Standard Quality" after failing quality tests at the stat...

The National Pharmaceutical Pricing Authority (NPPA) has also fixed the retail price of 12 scheduled formulations under Drugs (Prices Contr...

These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet. The ...

The regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...

Prices of those formulations, under price control, sold in hospitals increased as much as Rs 99 per mg, while those formulations which were...

In the diabetes drugs segment the average price of leading brands of some medicines is also higher between 10-3 times the MRP of generic dr...

Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40 per cent less with immediate effect

Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40 per cent less with immediate effect.

The prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformin+Glimepiride have been ...

As per the notification the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformi...

"The prices have been fixed / revised in respect of 43 formulation packs, both ceiling and retail price packs, under DPCO, 2013," NPPA said.

Drug pricing regulator NPPA has fixed the price of 108 non-scheduled formulation packs of 50 anti-diabetes and cardiac medicines.

Sanofi India's stock tanked 10.22 per cent to settle at Rs 2,900. In intra-day trade, the scrip plunged 10.99 per cent to Rs 2,875.

The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.

In a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation ...

In the wake of a government ban on top-selling diabetes drug, pioglitazone , the volumes are expected to shift to other classes such as fir...

Aventis Pharma and Themis Laboratories have signed a technology transfer agreement for fixed-dose combinations comprising glibenclamide (Da...